GlassScriptPhysician profile
Gregory Y Jia
NPI 1922084128
$3,895.05
in general payments reported to CMS, 2019-2025
30 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,338 · 2021: $21.01 · 2022: $1,164 · 2023: $512 · 2024: $498 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Entertainment: $13.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.46 |
| Entertainment | $13.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $651.59 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $353.69 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $327.37 | 2022-2023 | Urolift |
| Medtronic, INC. | $318.54 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $276.32 | 2019-2025 | Bulkamid |
| Coloplast Corp | $270.08 | 2019-2025 | |
| Pfizer INC. | $252.78 | 2019-2025 | |
| Urogen Pharma, INC. | $190.56 | 2022-2025 | Jelmyto |
| Medtronic USA, INC. | $178.66 | 2019 | |
| Bard Access Systems, INC. | $135.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.54 | 2022-2025 | |
| Antares Pharma, INC. | $90.67 | 2019 | |
| Endo Pharmaceuticals INC. | $89.53 | 2019-2023 | Aveed, Xiaflex |
| Abbvie INC. | $83.25 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $76.53 | 2022-2023 | Provenge |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $62.32 | 2021-2023 | Axonics, Bulkamid |
| Uroviu Corporation | $61.11 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $57.22 | 2019 | |
| Ferring Pharmaceuticals INC. | $52.16 | 2019 | |
| Verity Pharmaceuticals INC. | $38.87 | 2024-2025 | Trelstar |
| Laborie Medical Technologies Corp. | $37.91 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $20.78 | 2022 | |
| Telix Pharmaceuticals | $20.52 | 2023 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $19.99 | 2023 | Bard Urinary Drainage Bag |
| Accord Healthcare, INC. | $19.65 | 2023 | |
| Myovant Sciences INC. | $19.17 | 2022 | |
| Mission Pharmacal Company | $17.49 | 2019 | |
| Ethicon US, LLC | $14.74 | 2022 | |
| Provepharm INC. | $13.14 | 2024 | Bludigo |
| Janssen Biotech, INC. | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Jia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.